Nektar Therapeutics | ApexOnco - Clinical Trials news and analysis

x

“I am very impressed - it has become my go-to platform”

Chief Business Officer

US public biotech company

Click here for more information

Conferences Trial results

4 November 2024

SITC 2024 preview – late-breakers for Marengo and Indapta

Conferences Trial results

10 April 2024

AACR 2024 – Medicenna looks for a cytokine renaissance

After numerous IL-2 failures there are glimmers of hope for the group’s contender, MDNA11.

Subscribe to Nektar Therapeutics